Mevlit Íkbal

916 total citations
25 papers, 247 citations indexed

About

Mevlit Íkbal is a scholar working on Molecular Biology, Rheumatology and Cancer Research. According to data from OpenAlex, Mevlit Íkbal has authored 25 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Rheumatology and 6 papers in Cancer Research. Recurrent topics in Mevlit Íkbal's work include Carcinogens and Genotoxicity Assessment (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Ocular Diseases and Behçet’s Syndrome (3 papers). Mevlit Íkbal is often cited by papers focused on Carcinogens and Genotoxicity Assessment (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Ocular Diseases and Behçet’s Syndrome (3 papers). Mevlit Íkbal collaborates with scholars based in Türkiye, United Kingdom and United States. Mevlit Íkbal's co-authors include İbrahım Pirim, Mustafa Atasoy, Cihangir Aliağaoğlu, Ayhan Taştekın, Alper Han Çebi, Akçahan Gepdíremen, Rahmi Örs, Lokman Alpsoy, Güleray Ağar and Akın Aktaş and has published in prestigious journals such as Annals of the Rheumatic Diseases, Pharmacological Research and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

In The Last Decade

Mevlit Íkbal

25 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mevlit Íkbal Türkiye 11 64 54 48 28 28 25 247
Ataç Baykal Türkiye 12 15 0.2× 18 0.3× 32 0.7× 33 1.2× 27 1.0× 26 348
Wei‐Dong Yu China 12 18 0.3× 6 0.1× 119 2.5× 14 0.5× 22 0.8× 24 329
Lovorka Batelja Vuletić Croatia 10 23 0.4× 11 0.2× 55 1.1× 5 0.2× 29 1.0× 24 270
Danial Jahantigh Iran 13 34 0.5× 6 0.1× 103 2.1× 56 2.0× 129 4.6× 29 340
Abolfazl Mehdizadehkashi Iran 10 12 0.2× 11 0.2× 31 0.6× 9 0.3× 110 3.9× 39 404
Hongbin Gao China 10 6 0.1× 24 0.4× 152 3.2× 82 2.9× 20 0.7× 24 374
Archana Padmanabhan Nair India 11 8 0.1× 118 2.2× 28 0.6× 11 0.4× 14 0.5× 28 334
H Høyer Denmark 9 46 0.7× 11 0.2× 62 1.3× 3 0.1× 17 0.6× 15 336
Katherine S. Held United States 9 8 0.1× 40 0.7× 78 1.6× 15 0.5× 76 2.7× 13 313
Junqi Wang China 12 16 0.3× 5 0.1× 104 2.2× 52 1.9× 13 0.5× 54 362

Countries citing papers authored by Mevlit Íkbal

Since Specialization
Citations

This map shows the geographic impact of Mevlit Íkbal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mevlit Íkbal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mevlit Íkbal more than expected).

Fields of papers citing papers by Mevlit Íkbal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mevlit Íkbal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mevlit Íkbal. The network helps show where Mevlit Íkbal may publish in the future.

Co-authorship network of co-authors of Mevlit Íkbal

This figure shows the co-authorship network connecting the top 25 collaborators of Mevlit Íkbal. A scholar is included among the top collaborators of Mevlit Íkbal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mevlit Íkbal. Mevlit Íkbal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Çebi, Alper Han, et al.. (2020). MicroRNA Expression Levels in Patients with Hashimoto Thyroiditis: A Single Centre Study. Endocrine Metabolic & Immune Disorders - Drug Targets. 21(6). 1066–1072. 3 indexed citations
2.
Çebi, Alper Han, Ferhat Demir, Mevlit Íkbal, & Mukaddes Kalyoncu. (2020). Plasma microRNA levels in childhood IgA vasculitis. Clinical Rheumatology. 40(5). 1975–1981. 2 indexed citations
3.
Çaksen, Hüseyîn, Hayrettin Okut, & Mevlit Íkbal. (2019). Karyotype analysis in children with idiopathic intellectual disability. PubMed. 19(1). 57–59. 1 indexed citations
4.
Çebi, Alper Han, et al.. (2017). Interleukin-6 and interleukin-17 gene polymorphism association with celiac disease in children. The Turkish Journal of Gastroenterology. 28(6). 471–475. 13 indexed citations
5.
Akdemir, Fatih, Şener Taşdemir, Ömer Atış, et al.. (2014). A novel insertion mutation identified in exon 10 of the MEFV gene associated with Familial Mediterranean Fever. BMC Medical Genetics. 15(1). 74–74. 2 indexed citations
6.
Karaman, Ali̇, et al.. (2012). Phototherapy causes a transient DNA damage in jaundiced newborns. Drug and Chemical Toxicology. 36(1). 88–92. 16 indexed citations
7.
Yılmaz, Mehmet Birhan, et al.. (2012). IL-10 AND IL-17 GENE POLYMORPHISMS IN ADULT IDIOPATHIC THROMBOCYTOPENIC PURPURA. 1 indexed citations
8.
Íkbal, Mevlit, et al.. (2011). The evaluation of genotoxic potential of ornidazole, nitroimidazole, in lymphocyte culture of patients with amebiasis. Drug and Chemical Toxicology. 34(2). 162–166. 10 indexed citations
9.
Erdem, Teoman, et al.. (2008). HLA Class I and Class II Genotyping in Patients with Chronic Urticaria. International Archives of Allergy and Immunology. 147(2). 135–139. 14 indexed citations
10.
Íkbal, Mevlit, et al.. (2006). The alteration of sister chromatid exchange frequencies in Behçet's disease with and without HLA‐B51. Journal of the European Academy of Dermatology and Venereology. 20(2). 149–152. 8 indexed citations
11.
Atasoy, Mustafa, et al.. (2006). Association of HLA class I and class II alleles with psoriasis vulgaris in Turkish population. Influence of type I and II psoriasis.. PubMed. 27(3). 373–6. 6 indexed citations
12.
Atasoy, Mustafa, Cihangir Aliağaoğlu, Orhan Şahin, Mevlit Íkbal, & Nesrin Gürsan. (2006). Linear atrophoderma of Moulin together with leuconychia: a case report. Journal of the European Academy of Dermatology and Venereology. 20(3). 337–340. 9 indexed citations
13.
Yı́ldı́rı́m, Mustafa, Mevlit Íkbal, Tülay Tos, et al.. (2005). Genotoxicity of Thallium-201 in Patients with Angina Pectoris Undergoing Myocardial Perfusion Study. The Tohoku Journal of Experimental Medicine. 206(4). 299–304. 4 indexed citations
14.
Íkbal, Mevlit, et al.. (2004). Genotoxic Evaluation of the Antibacterial Drug, Ciprofloxacin, in Cultured Lymphocytes of Patients with Urinary Tract Infection. TURKISH JOURNAL OF MEDICAL SCIENCES. 34(5). 309–313. 6 indexed citations
15.
Pirim, İbrahım, et al.. (2004). HLA class I and class II genotyping in patients with Behcet's disease: a regional study of eastern part of Turkey. Tissue Antigens. 64(3). 293–297. 54 indexed citations
16.
Íkbal, Mevlit, et al.. (2004). The assessment of genotoxic effects in lymphocyte cultures of infants treated with chloral hydrate. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 564(2). 159–164. 26 indexed citations
17.
Íkbal, Mevlit, et al.. (2003). Association of sister chromatid exchange frequencies in patients with ankylosing spondylitis with and without HLA-B27. Annals of the Rheumatic Diseases. 62(8). 775–777. 3 indexed citations
18.
Gepdíremen, Akçahan, et al.. (1998). Effects of norepinephrine on NMDA‐induced neurotoxicity in cerebellar granular cell culture of rat pups. Fundamental and Clinical Pharmacology. 12(5). 517–520. 2 indexed citations
19.
Aktaş, Akın, et al.. (1998). High frequency of sister chromatid exchanges in lymphocytes of the patients with Behcet's disease. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 397(2). 235–238. 13 indexed citations
20.
Íkbal, Mevlit, et al.. (1997). Sister chromatid exchange analysis in patients exposed to low dose of iodine-131 for thyroid scintigraphy. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 393(3). 259–262. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026